Skip to content
Catalyst

metforminPapers

Papers about metformin

papers
3,985
41 years, by papers

Newest first

3,901 to 3,950 of 3,985

Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin

  • Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes?

    The Journal of family practice1999PMID 10907625

  • Acarbose vs. bedtime NPH insulin in the treatment of secondary failures to sulphonylurea-metformin therapy in type 2 diabetes mellitus.

    Diabetes, obesity & metabolism1999PMID 11221809

  • Metformin and contrast media--a dangerous combination?

    Clinical radiology1999PMID 9915507

  • Folate administration reduces circulating homocysteine levels in NIDDM patients on long-term metformin treatment.

    Journal of internal medicine1998PMID 10095804

  • Comparison of bedtime NPH insulin or metformin combined with glibenclamide in secondary sulphonylurea failure in obese type II (NIDDM) patients.

    JPMA. The Journal of the Pakistan Medical Association1998PMID 10323055

  • United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.

    Annals of internal medicine1998PMID 9454524

  • Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

    The New England journal of medicine1998PMID 9516221

  • Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes.

    Obesity research1998PMID 9526970

  • UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes. U.K. Prospective Diabetes Study Group.

    Diabetes care1998PMID 9538975

  • The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

    Diabetes care1998PMID 9589227

  • Evidence for dissociation of insulin- and weight-reducing effects of metformin in non-diabetic male patients with coronary heart disease.

    Diabetes research and clinical practice1998PMID 9597374

  • Effect of metformin on food intake in obese subjects.

    European journal of clinical investigation1998PMID 9693934

  • Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus.

    Diabetic medicine1998PMID 9702467

  • Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin.

    Diabetes care1998PMID 9727896

  • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

    Lancet (London, England)1998PMID 9742977

  • Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.

    Diabetes care1998PMID 9802752

  • Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes.

    Diabetes care1998PMID 9839093

  • Adding metformin versus insulin dose increase in insulin-treated but poorly controlled Type 2 diabetes mellitus: an open-label randomized trial.

    Diabetic medicine1998PMID 9868971

  • Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes.

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion1998PMID 9949668

  • Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients.

    Metabolism: clinical and experimental1997PMID 9030834

  • Metformin and exercise: no additive effect on blood lactate levels in health volunteers.

    Diabetic medicine1997PMID 9047091

  • Comparative effects of glibenclamide and metformin on ambulatory blood pressure and cardiovascular reactivity in NIDDM.

    Diabetes care1997PMID 9135928

  • Trivalent chromium and the diabetes prevention program.

    Medical hypotheses1997PMID 9247907Indexed under metformin in PubMed's chemical list

  • Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease.

    Scandinavian journal of clinical and laboratory investigation1997PMID 9350072

  • Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.

    Diabetes care1997PMID 9405908

  • The effect of metformin on blood pressure and metabolism in nondiabetic hypertensive patients.

    Journal of internal medicine1997PMID 9408071

  • Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study.

    The American journal of medicine1997PMID 9428831

  • Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

    The American journal of medicine1997PMID 9428832

  • Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.

    The Journal of clinical endocrinology and metabolism1996PMID 8636369

  • Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.

    The New England journal of medicine1996PMID 8687515Indexed under metformin in PubMed's chemical list

  • The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes.

    Diabetes care1996PMID 8720537

  • A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients.

    Diabetes care1996PMID 8742572

  • Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease.

    Journal of internal medicine1996PMID 8772621

  • Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (type 2) diabetes mellitus.

    Diabetic medicine1996PMID 8862952

  • Therapeutic effect of glibenclamide in a fixed combination with metformin or phenformin in NIDDM patients.

    Hormone and metabolic research1996PMID 8867905

  • The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group.

    Diabetes care1996PMID 8875083

  • Different effect of acute and chronic oral metformin administration on glucose and insulin response to bread and to pasta in non-insulin dependent diabetic patients.

    Diabetes research and clinical practice1996PMID 8877276

  • Food intake and dosage level, but not tablet vs solution dosage form, affect the absorption of metformin HCl in man.

    British journal of clinical pharmacology1996PMID 8904626

  • Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas.

    Diabetes care1996PMID 8908377

  • Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.

    The Journal of clinical endocrinology and metabolism1996PMID 8923861

  • Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus.

    Journal of clinical pharmacology1996PMID 8973990

  • Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.

    The Journal of clinical endocrinology and metabolism1995PMID 7608255

  • Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

    The New England journal of medicine1995PMID 7623902

  • United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years.

    BMJ (Clinical research ed.)1995PMID 7833731

  • Influence of food on the disposition of the antidiabetic drug metformin in diabetic patients at steady-state.

    Methods and findings in experimental and clinical pharmacology1995PMID 8577211

  • Short administration of metformin improves insulin sensitivity in android obese subjects with impaired glucose tolerance.

    Diabetic medicine1995PMID 8582131

  • Effect of metformin on glutathione and magnesium in normal and streptozotocin-induced diabetic rats.

    Journal of applied toxicology1995PMID 8666722

  • The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men.

    Blood pressure1994PMID 7704288

  • Reduction of the acute bioavailability of metformin by the alpha-glucosidase inhibitor acarbose in normal man.

    European journal of clinical investigation1994PMID 7818725

  • Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

    Diabetes care1994PMID 7821128

The next 35 papers

← Previous 50